While it is not yet available on the market, ongoing Retatrutide clinical trials have shown remarkable results, leaving everyone wondering whether Retatrutide can outperform existing treatments that are semaglutide and tirzepatide based
8 This procedure can assist in the diagnosis and management of benign and malignant pigmented lesions of the lips
When Adjusting Your Semaglutide Schedule Is Safe Moving your injection forward by one day is generally considered a minor schedule adjustment that does not require immediate medical intervention, especially if it is a one-time occurrence
GLP-1 medications can cause nausea, fatigue, or appetite changesbut if thyroid-like symptoms emerge, thyroid labs should be checked
Castellini G, Lo Sauro C, Mannucci E, Ravaldi C, Rotella CM, Faravelli C, et al
The clinical trial evidence indicates that tirzepatide is associated with better glycemic control and weight reduction than the conventional GLP-1 monotherapy, with the SURPASS clinical trial program being associated with HbA1c changes of up to 2.4% compared to baseline and weight reduction of more than 22% of the baseline weight at the highest dosage
